BLUEPRINT MEDICINES CORP shareholders Q2 2023

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.

BLUEPRINT MEDICINES CORP shareholders Q2 2023
NameSharesValueWeighting ↓
AIGEN INVESTMENT MANAGEMENT, LP 8,635$545,7320.08%
EFG Asset Management (Americas) Corp. 5,500$347,6000.08%
EFG CAPITAL INTERNATIONAL CORP. 5,500$347,6000.08%
EAGLE ASSET MANAGEMENT INC 204,385$12,917,1320.07%
Candriam S.C.A. 151,222$9,557,2310.07%
ClariVest Asset Management LLC 21,717$1,3730.07%
Hudson Bay Capital Management LP 146,600$9,265,1200.07%
SEGALL BRYANT & HAMILL, LLC 95,711$6,048,9360.06%
BROWN ADVISORY INC 635,196$40,144,4110.06%
Dana Investment Advisors, Inc. 19,694$1,244,6610.06%
WELLINGTON MANAGEMENT GROUP LLP 4,923,714$311,178,7250.06%
Mayflower Financial Advisors, LLC 6,817$430,8340.06%
PICTET ASSET MANAGEMENT SA 723,766$45,742,0110.05%
Rafferty Asset Management, LLC 141,997$8,974,2100.05%
PRICE T ROWE ASSOCIATES INC /MD/ 5,623,376$355,3990.05%
ALLIANCEBERNSTEIN L.P. 1,611,181$101,826,6390.04%
Zimmer Partners, LP 28,400$1,794,8800.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 111,531$7,048,7590.04%
E Fund Management Co., Ltd. 7,639$4830.04%
FMR LLC 6,708,137$423,954,2580.04%
External links

This page lists BLUEPRINT MEDICINES CORP's shareholders in Q2 2023. To view BLUEPRINT MEDICINES CORP's shareholder history, click here.